Tailored Mandates.Asymmetric Advantage.Math and Magic.

VCaaS is a model where a specialist manager builds and runs a venture capital capability on behalf of an institution: strategy, sourcing, diligence, execution and portfolio management. The institution retains control of capital and strategy.

It is a third route into venture, because the two conventional ones have structural limits.

Investing into an external VC manager is fast but passive. You are an LP in a blind pool: the mandate is the manager's, not yours, visibility is limited, and no capability transfers back. You buy exposure to venture, not a venture capability.

Building an internal team delivers alignment and control, but takes three to five years, carries permanent fixed cost, and requires competing for talent against pay and carry structures most institutions cannot match. It begins with no track record and therefore no deal access, and key-person departure resets the clock.

VCaaS combines the alignment of an internal team with the speed and cost of an external one. The mandate is built to your strategy, you retain decision rights and visibility, and the capability is operational from day one on a variable cost base, with the option to internalise over time.

A sole-LP fund is a dedicated vehicle backed by a single institution. The difference from a pooled fund is structural, not just strategic.

A pooled fund's terms are fixed the day it closes for a decade: strategy, pace, fees, reporting. They are the compromise that got several backers into one vehicle. A position in it inherits all of that, including the parts negotiated for someone else.

A sole-LP mandate has none to protect. Terms are set bilaterally and can be reset: fees tied to money actually deployed, reporting to your board's cadence, agreed exclusions for competitors or off-limits sectors, and direct sight of the pipeline rather than a quarterly summary written for a committee.

It also has a longer life. A pooled fund winds down on schedule and cannot change strategy midway without every backer agreeing. A sole-LP mandate evolves with yours and can be evergreen, recycling exit proceeds into new investment so the vehicle trends toward funding itself rather than relying on fresh capital from the backer.

Nor is there a queue: co-investment and reserves for later rounds are not rationed across other backers.

No. VCaaS is not corporate venture capital, and the distinction is worth drawing carefully. Corporate venture capital describes who provides the capital. VCaaS describes how the vehicle is run.

An in-house corporate venture team sits inside the organisation, and inherits its approval cycles, pay bands and shifting priorities. A VCaaS vehicle is independent: it moves at market speed, applies venture discipline, and survives a reshuffle.

It is also not only for corporates. The same structure serves governments, industry bodies, universities and family offices, and financial institutions, as an alternative to committing to someone else's fund. What they share is strategic intent without a reason to build a permanent investment desk.

It works alongside an existing corporate venture team as readily as instead of one: additional pipeline, eyes and ears in markets the team cannot cover, and reach into a region where you have no presence.

And when strategy changes, it is a landing place. Artesian takes on existing corporate venture portfolios when a parent steps back, managing them to an orderly outcome rather than a forced wind-down.

As much or as little as it wants. Control is a setting, not a fixed feature of the model.

Two things are always the backer's: the capital, and the mandate. You set the region, sector, stage and pace, and no investment is made outside them.

Everything above that is chosen. At one end, the backer sets the mandate, receives reporting, and otherwise leaves the manager to run it. At the other, it holds seats on the investment committee with veto rights over every deal, works alongside the team on sourcing and diligence, and treats the portfolio as distributed research and development, extending the internal programme rather than duplicating it, and building an acquisition pipeline alongside it. Most start close and step back as confidence builds.

The distance is a feature, not a compromise. A venture programme touches hundreds of startups a year: most are declined, some fail publicly, a few attract attention no institution wants. An independent manager is the front door for all of it. The backer keeps its influence over what gets funded, without its name on every conversation that goes nowhere.

Yes. A sole-LP fund can deliver both, and venture is unusual in that respect. Few asset classes produce a financial return and a strategic one from the same investment.

What "strategic" means depends on the backer. For a government it is sovereign capability. For a corporate it is distributed research and development and an acquisition pipeline. For a financial institution or family office it is a dedicated mandate in a niche a generalist fund cannot reach.

The mix is set by the backer, and it is a dial rather than a switch. A broad mandate carries no penalty: like any venture fund, it can chase outliers and transformational outcomes. Strategic fit determines where we look; it never lowers the bar for what we back. A narrower one, a constrained market chosen for a specific strategic outcome, trades some of that upside for certainty of impact, and should carry a moderate return target from the outset.

Where the two pull against each other, we say so before the mandate is signed rather than leaving it to be discovered.

Three things can move in a sole-LP mandate: what it covers, when capital deploys, and how much there is.

Focus is the first. Sector, stage and geography can be narrowed, widened or redirected as strategy changes. Existing holdings continue on their original terms; the change applies to what comes next.

Timing is the second. A conventional fund runs on a clock: it must deploy within a fixed period and return capital by a fixed date, because the manager needs a track record to raise the next fund. So capital goes out into frothy markets, and winners are sold early.

A sole-LP mandate has no such clock. Deployment can be paused when pricing is poor and accelerated when it is not. Reserves can be concentrated behind a company that is working, or withheld. Positions can be held past the point a fund would have to sell.

Capital is the third. The backer can top up the mandate as conviction grows, or let realisations recycle so the vehicle extends its reach without new commitment.

None of this is structurally constrained. The discipline comes from process and governance: every change is a decision, taken at a set review.

As much as it chooses. But this is the one dial where turning it up changes the fund's outcomes, not just its governance.

Builders now choose their investors. Capital is abundant; useful capital is not. An institution can offer what a generalist venture fund cannot: deep domain expertise, a first customer, a distribution channel, an industry network, a pilot or procurement pathway, project collaboration, and in time a credible acquirer.

That makes a VCaaS mandate a different kind of money on the register, complementary to traditional venture investors rather than competing with them, and attractive to builders deliberately diversifying away from a table of purely financial backers.

The effect runs both ways. The institution's contribution helps portfolio companies get from invention to deployment. It also wins allocation in competitive rounds, and brings companies to the door that would not otherwise take the meeting.

Deal access is the scarcest thing in venture, and money alone does not buy it.

Deal flow is three problems: seeing enough, seeing it early, and seeing what you would not have thought to look for.

Volume comes from the platform. The mandate plugs into a funnel that already exists: outbound discovery, inbound sharpened by a mandate publicly known to fund one thing, and thousands of companies reviewed a year. It also absorbs the enquiries that arrive at the backer's own door: every approach gets a professional answer, and none of it consumes internal time.

Precision comes from the mandate itself. A defined sector and stage turns a firehose into a field that can be worked systematically and worldwide: every relevant company mapped, not just the ones that arrive. The narrower the mandate, the closer coverage gets to complete.

The backer's own operations add a channel no fund has: suppliers, customers, research partners and industry bodies surface companies long before they reach a pitch deck.

A focused mandate is not a blinkered one. The same discipline that maps a sector properly also looks outside it, for the technology emerging in an unrelated industry that could reshape the backer's own. Disruption rarely arrives from the companies an institution already watches.

The starting point is not how much to invest but why the market has not invested already. Usually the capability a government wants needs investors willing to value a strategic return alongside a financial one, and conventional venture capital is driven by financial return alone.

That capability might be sovereign: defence, quantum, advanced manufacturing. It might be regional, where success looks less like one technology than a cluster of companies, skilled jobs and local capital. Either way the fund must be commercially credible, since returns are what bring private investors alongside, recycle capital into the next generation of companies, and show the market the sector is worth backing.

A mandate drawn carefully, clear about what the fund is built to create and what sits outside its scope, fills that gap without displacing investors already active, and instead pulls them in alongside. Settling mandate, governance and reporting before going to tender is what allows the fund to move at commercial speed while keeping public accountability intact.

None of this requires building an investment agency: Artesian has built and run government-backed funds across sovereign and regional priorities, beginning with mandate design before capital is committed.

Yes. An industry organisation can invest in the gap between research and commercialisation. The question is not whether the sector needs more research, but whether technologies are making the transition from research into companies, products and adoption.

A venture fund lets an industry organisation invest in that gap, backing companies developing solutions for the sector and looking beyond it for technologies that could improve its productivity or resilience. It extends a research, development and extension programme into commercialisation rather than competing with it, and successful investments return capital that can be reinvested, drawing private investors and expertise into a sector that might not otherwise attract them.

An industry organisation does not represent a single customer. Its members span large incumbents and small operators, different points in the supply chain and different regions. Its mandate must translate those competing interests into a small number of investable priorities, with clear rules on what it will and will not back, and how the benefits reach members.

None of this requires becoming a venture capital firm: the organisation sets the mandate and holds the governance; Artesian provides the investment team, deal flow and portfolio management. Artesian has applied this in Australian agriculture through GrainInnovate and the world-first horticulture fund with Hort Innovation, beginning with mandate design before capital is committed.

A corporation can do this by establishing a dedicated fund and outsourcing the investment function. The corporation sets the thesis, decides what strategic outcomes it wants and retains the commercial relationships; Artesian provides the venture capability: deal flow, screening and diligence, investment execution, portfolio management, and the relationships that connect portfolio companies to the parts of the business that can become customers or partners.

This matters because venture investing differs from corporate development. A team excellent at evaluating established businesses and executing acquisitions will find early-stage investing needs different networks and judgement: acquisition instincts applied to startups tend to produce inappropriate terms, or governance that makes a company less attractive to its next investors.

The advantage is speed and flexibility: the corporation can start investing while an internal team would still be recruiting, scale as the opportunity develops, change the mandate as priorities do, or wind down without carrying a permanent team. Where the aim is eventually to own the capability, it transfers progressively, with Artesian moving from manager to adviser.

The choice is not between building a capability from scratch and not investing at all: the corporation starts with one already operating, and decides over time how much to own.

A fund position gives an institution exposure to venture. A mandate gives it a venture programme of its own: a thesis aligned to its objectives, control over pacing, and reporting and governance built around the institution rather than an external fund.

This is not an alternative to fund positions. For an institution already invested across venture and private equity, the greater value may be in making those relationships work harder. Co-investment from existing managers is often the best opportunity an institution sees, but it arrives with short decision windows and needs specialist assessment an institution without a venture team cannot provide. A mandate supplies that capability, so those opportunities can be acted on rather than passed.

It also lets an institution invest deliberately rather than incidentally. Exposure built through fund positions is the sum of what those managers happen to cover, leaving sectors, stages or geographies underweight; a mandate can be pointed straight at the gap, and reach emerging managers and direct opportunities without building that infrastructure in-house or paying a fund-of-funds fee layer.

Through a dedicated mandate: institutional-grade venture capability, sized and designed around the family, running on the same infrastructure as larger programmes. Thousands of companies sourced each year, structured diligence, execution, portfolio management and reporting. All without building an investment team or committing to a conventional fund.

The advantage is not simply access, but selection. Most family offices already receive venture opportunities through friends, advisers and inbound introductions, but that pipeline reflects who the family knows, not where the best opportunities lie. A mandate replaces episodic deal flow with a defined thesis, systematic sourcing and disciplined portfolio construction, so investments are selected as part of a strategy rather than accumulated one by one.

The strategy remains the family's. It reflects what the family wants to support and what it will not: sustainability, impact, or sectors connected to the operating business or the origins of the family's wealth. The family sets the mandate, retains decision-making authority and full transparency.

It can also carry more than capital across generations. Venture gives the next generation a practical way to build judgement: sitting alongside professionals on the investment committee, assessing real companies and making real decisions. They learn stewardship before they are expected to exercise it alone.

The problem is rarely a shortage of ideas. Universities bring together research, intellectual property, students, alumni and industry relationships, but they sit disconnected, with no systematic way to find the best of them, match them with the right people and turn them into investable companies.

A dedicated venture fund becomes the connective tissue: a shared platform where researchers find commercial talent, students work with new technologies, alumni contribute expertise and capital, and industry partners become customers and co-investors. The strongest ideas get validation, company formation and early capital.

It must be independently managed. A university is at once the source of the research, the owner of the intellectual property and an investor in the company, and terms that maximise its position at formation can weaken the incentives of the people building the company and deter future investors. An arm's-length manager negotiates with the whole funding journey in mind, protecting the university's interests while keeping the business fundable.

Done well, the model compounds. Returns recycle into the next generation of ventures, until the university is not merely a source of research but the centre of an ecosystem that repeatedly forms, finances and grows companies.

Artesian manages a university venture fund and is a founding shareholder in an innovation precinct alongside universities.

A corporate venture portfolio has three paths: sell, run it off, or transfer it to a specialist manager. The greatest value destruction occurs in the middle: pro-rata rights lapse, board seats go unattended and the companies struggle to get decisions. The loss stays invisible until an exit makes it permanent.

A sale gives speed and certainty at a price reflecting the seller's urgency and the buyer's information advantage. It also carries signalling risk: co-investors may read a strategy change as a loss of confidence in the companies themselves.

Transferring it preserves more options, because the work runs at both ends. Venture portfolios are made by one or two companies, which need follow-on capital and someone at the table. The long tail needs the opposite: dormant holdings closed out, board seats resigned and small positions realised, so nothing is left on the parent's books to explain.

Rather than paying to administer a declining portfolio, the manager is paid on value preserved and returns realised, so the parent steps away without forcing a sale and keeps its share of any upside.

A change in corporate strategy should not become value destruction, or a reputational event. Artesian takes on legacy portfolios on this basis.

A sole-LP mandate has no fixed minimum, but a threshold below which the portfolio mathematics stops working. The amount depends on stage, sector, target ownership and follow-on requirements, but as a guide a dedicated early-stage mandate becomes viable at around $20 million committed over five years, about $4 million a year.

The constraint is portfolio construction, not operating cost. Venture returns are driven by a small number of companies, so the portfolio must be broad enough to contain outliers while each position remains meaningful, with capital retained to back the strongest through later rounds. Below the threshold a mandate risks owning too few companies, holding stakes too small to carry influence, and exhausting its capital before the winners emerge, weakening both the financial return and the strategic value it was created to deliver. Later-stage strategies need more capital, or much greater concentration.

We would rather establish that at the outset than discover it three years into deployment. It does not have to end the conversation: many institutions begin with a narrower engagement, whether diligence on a specific opportunity, an ecosystem map, or a scouting programme alongside an existing team. They move to a dedicated mandate once the strategy, pipeline and commitment are clear.

Artesian's fees depend on the work. Managing capital, operating fund infrastructure and providing discrete advice are different services, so each is priced differently.

A venture mandate combines a management fee with participation in performance. The management fee pays for the team, systems and investment platform required to source, assess, execute and manage the portfolio. Performance participation aligns our economics with the value the mandate creates. Because each mandate is negotiated directly rather than inherited from a pooled fund, its economics can be designed around the backer's objectives, including setting the management fee against capital actually deployed rather than capital committed. Where a mandate seeks strategic as well as financial returns, that alignment can reflect both.

Fund administration is charged as a proportion of the fund's management fee, so the cost scales with the fund rather than becoming a separate fixed overhead.

Advisory work, such as mandate design, ecosystem mapping or diligence on a specific opportunity, is priced as a fixed fee for a clearly defined engagement and deliverable.

There is no single rate because no two mandates ask the same thing. The scope, fee basis, performance arrangements and expected cost are set out in full before anything is signed.

Usually both mandates invest. An overlapping opportunity is governed by a written allocation policy, not negotiated after the deal appears. It reflects a fiduciary duty: mandates must be treated fairly and equitably over time.

The default is to offer the opportunity to every mandate for which it is eligible. Each investment committee makes its own decision. If more than one approves and the available allocation cannot satisfy both, it is divided pro rata based on capital invested, rather than funds under management, which is not comparable across different mandate structures.

There are three exceptions. Backers can agree a different allocation in writing beforehand. This is common because two strategic investors on the register will often strengthen and validate a company rather than diminish either investor's position. If a backer originates an opportunity independently of Artesian, that opportunity belongs to the backer. And companies are not fungible assets: builders and existing shareholders ultimately decide who joins the register, and no manager can guarantee an allocation they do not control.

Artesian already manages overlapping mandates in agrifood for corporate, government and institutional backers. The allocation policy is disclosed and agreed during diligence, before a mandate begins, not after an opportunity arises.

Custody, valuation and audit are deliberately separated. Legal title is held through the trustee, custodian or fund vehicle specified in the constituent documents, not by the people making investment decisions. Fund administration is carried out by Artesian Operations, a separate team with its own reporting line, and every fund is independently audited each year.

Venture valuation necessarily involves judgement, but not unconstrained discretion. Each fund follows a documented policy based on the International Private Equity and Venture Capital Valuation Guidelines and applicable accounting standards. Holdings are assessed at each financial year end and whenever a financing or material change warrants it. Material changes to the methodology are governed by the fund documents and, where required, backer approval.

An arm's-length funding round is important evidence of fair value, not an automatic mark. Its terms, timing and investor composition matter, alongside company performance and market conditions. Cost may remain the best evidence where little has changed; equally, the absence of a round cannot justify ignoring impairment. Artesian cannot mark up a holding simply because the investment team believes it is worth more.

The precise arrangements vary by vehicle and are disclosed in full before commitment. Artesian operates under the applicable licensing arrangements in each market where it manages capital.

Continuity is not left to goodwill. Each mandate identifies an accountable partner and includes key-person provisions agreed with the backer. If that person departs or can no longer perform the role, the mandate triggers the backer's contractual rights; the backer is not left to discover the change and negotiate a response afterwards.

The next protection is institutional. Investment decisions are made by committee, venture leadership is shared between co-heads, and responsibility for sourcing, diligence, execution and portfolio management is distributed across the firm. Pipeline history, builder relationships, investment records and portfolio knowledge are held in Artesian's systems, so the mandate does not leave with one person.

That operating structure is supported by a Board-level succession framework covering partners and partner-equivalent roles. It is reviewed at least annually and whenever circumstances change, with defined arrangements for an unplanned departure: interim leadership, reassignment of authority, backer communication and enhanced Board oversight through the transition.

Succession is developed internally before it is needed. Artesian's senior leaders have typically progressed through multiple roles over long tenures, creating real coverage rather than a plan assembled after a departure. The succession framework, current key-person coverage and contractual protections are available for review during diligence.

Within a year you should know whether the mandate works as an investment process. Within two, whether it is creating strategic value. Financial performance may take longer to establish.

The two run on different clocks. Strategic value appears early through pilots, partnerships, procurement opportunities and a clearer view of the technologies approaching your industry. Venture returns depend on a small number of companies whose value is established through liquidity, not interim marks. Meaningful exits often begin around years five to seven and continue well beyond.

Between those points, the evidence is about selection and validation. In the first year you can assess pipeline breadth and quality, selectivity, and whether investments match the agreed thesis. By years three and four the market begins to provide stronger signals: independent investors lead later rounds, portfolio companies win commercial contracts and third-party capital invests alongside yours. None guarantees an outcome, but together they show a portfolio developing in the way that precedes returns.

Interim valuations are the weakest measure of early success. A manager presenting strong performance in year two is presenting marks, not results. We would rather agree the measures at the outset, whether financial, strategic or operational, and report consistently against them until the financial clock catches up.

A mandate should be designed for the possibility that priorities will change. Its documents establish how strategy can be reviewed, amended, paused or ended before any capital is committed, so a change in direction does not have to become a disorderly exit.

Sector, stage, geography and pace can be narrowed, widened or redirected as objectives evolve. That flexibility is a principal advantage over a pooled fund whose thesis is fixed at first close. But flexibility should not become market timing. Venture is cyclical, and the urge to change direction is often strongest after a difficult quarter rather than a real change in strategy. Material changes are therefore considered through scheduled reviews, against the objectives and evidence agreed at the outset.

The unavoidable limit is that invested capital cannot be recalled. Any change applies to capital not yet deployed; existing holdings and binding commitments remain in place. Those companies must still be governed, supported and ultimately realised.

Stopping new investment is not the same as forcing a sale. Deployment can be paused or the investment period ended, while the portfolio continues to be managed towards orderly exits. A change in priorities need not become a discount, or a reputational event.

If only one arrives, the mandate has succeeded on one objective and failed on the other. The two cannot be netted off: strategic value does not erase a poor investment result, and good returns do not prove the programme delivered for the organisation.

The first failure is a mandate optimised for adoption rather than investment quality: a procurement programme with equity attached, at a price no disciplined investor should pay. Strategic fit determines where we look; investment merit determines what receives capital.

The opposite failure is as real and less visible. A portfolio can perform financially while delivering nothing back to the organisation: no adoption, partnerships, capability or market intelligence anyone inside it can point to. Strategic value is not an automatic by-product of good investing. It requires accountability, in the programme and inside the backer, for connecting portfolio companies with business units that can pilot, procure from or partner with them.

The discipline is to define, measure and report them separately from the outset, so neither shelters behind a blended score. If they diverge persistently, the scheduled review asks why: whether the thesis, the engagement model, internal ownership or objectives need to change. The divergence becomes a decision to manage, not a result discovered at the end.

Yes: a fund should be the consequence of an innovation strategy, not a substitute for one.

The work begins with what the organisation is trying to achieve, the outcomes sought, financial and strategic, how trade-offs between them are resolved, and where it has a real advantage. It maps the ecosystem, identifies what is missing and tests which mechanism fits: a fund, precinct, partnership, programme or a combination.

The harder task is alignment that lasts. Venture operates over a decade; executives, budgets and priorities change much faster. Programmes falter not because the thesis was unsound, but because the champion moves on, or conditions turn and no one beyond the original group can explain why it still matters.

Good design turns an individual initiative into an institutional mandate. The board, executive and participating business units agree objectives, measures, risk appetite, decision rights and governance before capital is deployed. Those choices are documented while everyone is aligned, so the strategy survives changes in leadership and markets.

Artesian undertakes this as a standalone engagement, not a process with a predetermined conclusion. The output is an evidence-based recommendation and implementation blueprint. Sometimes that leads to a mandate; sometimes the answer is a different instrument, or no capital at all.

Artesian does both, and in several cases the infrastructure came before the capital. A fund can invest in companies, but it cannot create a functioning innovation ecosystem by itself. That requires the machinery around the capital: accelerators to find and develop builders, precincts to connect research and industry, fund structures to hold investments, and administration to operate the vehicles. Where an essential piece was missing, Artesian has built it rather than waiting for the market to provide it.

Some of that infrastructure Artesian established, funded and operated on its own account. Other parts required universities, corporations and governments around the same table. In those cases, Artesian has built alongside those institutions as a founding shareholder, participating in shared governance rather than seeking control.

Each organisation has its own team, mandate and balance sheet. They are not holdings inside backer portfolios, and backer mandates do not pay for their development or operation.

For a government, industry body, university or corporation, this creates a broader conversation than whether to establish a venture fund. If investable companies exist but capital is missing, a fund may be the answer. If the missing piece is builder development, commercialisation capability, institutional connection or the structure through which capital can operate, the infrastructure may need to come first. Often the answer is some combination of both. The work begins by identifying what is absent, not by assuming the solution is another pool of capital.

A multi-LP fund is a pooled vehicle: several backers behind a shared thesis, run alongside sole-LP mandates rather than instead of them.

Two things usually create the need. The first is success. A sole-LP mandate is sized and scoped to one institution's strategy, and a company that breaks out will eventually need more capital than that mandate should hold in a single position. Rather than sell early or let the position dilute, Artesian can raise a Breakout Fund alongside it, a growth-stage vehicle built around companies that have already proved themselves inside existing mandates. The original backer keeps its position and can follow on; other institutions gain access to companies they could not have sourced.

The second is scale. A dedicated mandate does not make sense below a certain size, and a pooled fund lets an institution back the same strategy at a commitment that suits it.

FAaaS solves the sequencing problem facing an emerging fund manager. Before accepting its first dollar, a manager needs a licensing framework, compliance, fund accounting, administration and investor reporting. Yet before the fund has capital and scale, building that infrastructure is difficult to justify. The cost and complexity can stop a credible investment strategy before the first cheque is written.

Artesian provides the operating layer underneath the fund, using the same institutional infrastructure that supports its own vehicles. This allows the manager to launch without first having to assemble a complete back office, while giving investors the governance, controls and reporting they expect from day one.

The division of responsibility is clear. The fund belongs to the manager, not Artesian. The manager sets the thesis, raises capital, selects companies, supports builders and remains accountable to its investors. Artesian provides the licensed, regulated machinery that allows those activities to operate properly.

FAaaS therefore does more than reduce overhead. It allows specialist and first-time managers to establish an institutional-quality fund from day one, concentrate their resources on investing and build a track record on a platform designed to support them as they grow.